Quantcast
Search Daily Dose & Film Annex
Loading

BIO SmartBrief

Daily Dose Newsletter

Wednesday
Apr182012

AtheroNova ($AHRO) C.E.O. Thomas W. Gardner on atherosclerosis market size (video)

AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.

In this film, AtheroNova C.E.O. Thomas W. Gardner speaks about the market size for atherosclerosis:

Watch more on Film Annex

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>
« Idenix Pharmaceuticals ($IDIX) announces initial data from phase I clinical trial of IDX719 | Main | NeoStem to Present at BioCentury Future Leaders in the Biotech Industry Conference - $NBS »